CYP27A1 and secondary hyperparathyroidism: They found a significant prevalence of MVF (17.5%) and noted that the RYGB group exhibited lower BMD values at various sites compared to the SG group, alongside higher rates of secondary hyperparathyroidism and bone turnover markers such as CTX and alkaline phosphatase.